Olivier Peyruchaud
Overview
Explore the profile of Olivier Peyruchaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Briolay A, Duboeuf F, Delplace S, Brizuela L, Peyruchaud O, Magne D, et al.
Bone Rep
. 2024 Nov;
23:101810.
PMID: 39493871
Biomechanical stimulation is proposed to occupy a central place in joint homeostasis, but the precise contribution of exercise remains elusive. We aimed to characterize in vivo the impact of mechanical...
2.
Meaux M, Regnier M, Portefaix A, Borel O, Alioli C, Peyruchaud O, et al.
Front Pediatr
. 2023 Mar;
11:1094705.
PMID: 36861069
Autotaxin (ATX) is a secreted enzyme with a lysophospholipase D activity, mainly secreted by adipocytes and widely expressed. Its major function is to convert lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA),...
3.
Saier L, Ribeiro J, Daunizeau T, Houssin A, Ichim G, Barette C, et al.
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293074
Metastases are the main cause of death in cancer patients, and platelets are largely known for their contribution in cancer progression. However, targeting platelets is highly challenging given their paramount...
4.
Meaux M, Alioli C, Linglart A, Lemoine S, Vignot E, Bertholet-Thomas A, et al.
J Clin Endocrinol Metab
. 2022 Sep;
107(12):3275-3286.
PMID: 36112422
Context: X-linked hypophosphatemia (XLH) is a rare genetic disease caused by a primary excess of fibroblast growth factor 23 (FGF23). FGF23 has been associated with inflammation and impaired osteoclastogenesis, but...
5.
Bessueille L, Kawtharany L, Quillard T, Goettsch C, Briolay A, Taraconat N, et al.
Transl Res
. 2022 Jun;
251:2-13.
PMID: 35724933
Calcium accumulation in atherosclerotic plaques predicts cardiovascular mortality, but the mechanisms responsible for plaque calcification and how calcification impacts plaque stability remain debated. Tissue-nonspecific alkaline phosphatase (TNAP) recently emerged as...
6.
Alioli C, Demesmay L, Peyruchaud O, Machuca-Gayet I
Int J Mol Sci
. 2022 Apr;
23(7).
PMID: 35408784
Lysophosphatidic acid (LPA) is a natural bioactive phospholipid with pleiotropic activities affecting multiple tissues, including bone. LPA exerts its biological functions by binding to G-protein coupled LPA receptors (LPA) to...
7.
Su J, Krock E, Barde S, Delaney A, Ribeiro J, Kato J, et al.
Brain Behav Immun
. 2022 Jan;
101:214-230.
PMID: 35026421
Inflammatory and neuropathic-like components underlie rheumatoid arthritis (RA)-associated pain, and lysophosphatidic acid (LPA) is linked to both joint inflammation in RA patients and to neuropathic pain. Thus, we investigated a...
8.
Bernardor J, Alioli C, Meaux M, Peyruchaud O, Machuca-Gayet I, Bacchetta J
Curr Osteoporos Rep
. 2021 Nov;
19(6):553-562.
PMID: 34773213
Purpose Of Review: To describe the methods that can be used to obtain functional and mature osteoclasts from peripheral blood mononuclear cells (PBMCs) and report the data obtained with this...
9.
Quinaux T, Bertholet-Thomas A, Servais A, Boyer O, Vrillon I, Hogan J, et al.
Cells
. 2021 Sep;
10(9).
PMID: 34572146
Bone complications of cystinosis have been recently described. The main objectives of this paper were to determine in vitro the impact of CTNS mutations and cysteamine therapy on human osteoclasts...
10.
Estrada-Meza J, Videlo J, Bron C, Saint-Beat C, Silva M, Duboeuf F, et al.
Endocrinology
. 2021 May;
162(7).
PMID: 33999998
Tamoxifen is a selective estrogen receptor modulator used to activate the CREERT2 recombinase, allowing tissue-specific and temporal control of the somatic mutagenesis to generate transgenic mice. Studies integrating development and...